Cited by 769SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesViral Infections and Outbreaks Research

Structural insights into coronavirus entry

Open access
M. Alejandra Tortorici, David Veesler·2019·Advances in Virus Research

Abstract

Coronaviruses (CoVs) have caused outbreaks of deadly pneumonia in humans since the beginning of the 21st century. The severe acute respiratory syndrome coronavirus (SARS-CoV) emerged in 2002 and was responsible for an epidemic that spread to five continents with a fatality rate of 10% before being contained in 2003 (with additional cases reported in 2004). The Middle-East respiratory syndrome coronavirus (MERS-CoV) emerged in the Arabian Peninsula in 2012 and has caused recurrent outbreaks in humans with a fatality rate of 35%. SARS-CoV and MERS-CoV are zoonotic viruses that crossed the species barrier using bats/palm civets and dromedary camels, respectively. No specific treatments or vaccines have been approved against any of the six human coronaviruses, highlighting the need to investigate the principles governing viral entry and cross-species transmission as well as to prepare for zoonotic outbreaks which are likely to occur due to the large reservoir of CoVs found in mammals and birds. Here, we review our understanding of the infection mechanism used by coronaviruses derived from recent structural and biochemical studies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/bs.aivir.2019.08.002

Cites

133 of 133 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The spike protein enables viral entry into host cells through the ACE-2 receptor.

    “The S gene encodes for the prominent homotrimeric, type I fusion and transmembrane glycoprotein which enables viral entry into the host target cell through the angiotensin-converting enzyme-2 (ACE-2) receptor [5, 6].”

    From Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe (2022) · cites this paper as [5]

    The Introduction says spike promotes host attachment and membrane fusion during entry, and “Diversity of CoV receptors and entry mechanisms” identifies ACE2 as an entry receptor for SARS-CoV and HCoV-NL63. The same section describes other coronaviruses using different receptors, so the source does not support ACE2 as the entry receptor for coronaviruses generally. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • The spike protein mediates entry into host cells by binding the ACE-2 receptor.

    “The S gene encodes for the prominent homotrimeric, type I fusion and transmembrane glycoprotein which enables viral entry into the host target cell through the angiotensin-converting enzyme-2 (ACE-2) receptor [5, 6].”

    From Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe (2022) · cites this paper as [5]

    The Introduction says the spike protein promotes host attachment and membrane fusion during entry. The section “Diversity of CoV receptors and entry mechanisms” identifies ACE2 as an entry receptor for SARS-CoV and HCoV-NL63, but also says other coronaviruses use different receptors. The unqualified claim that spike-mediated entry occurs through ACE2 is therefore broader than the source supports. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • The S gene encodes a homotrimeric type I fusion transmembrane glycoprotein that enables viral entry through the ACE-2 receptor.

    “The S gene encodes for the prominent homotrimeric, type I fusion and transmembrane glycoprotein which enables viral entry into the host target cell through the angiotensin-converting enzyme-2 (ACE-2) receptor [5, 6].”

    From Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe (2022) · cites this paper as [5]

    The Introduction describes spike (S) as a trimeric class I fusion protein involved in viral entry, and Prefusion S architecture identifies its transmembrane region. However, Diversity of CoV receptors and entry mechanisms identifies ACE2 as an entry receptor for SARS-CoV and HCoV-NL63, while other coronaviruses use different receptors. The claim does not limit its ACE2 assertion to those viruses. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tortorici, M. A., & Veesler, D.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • University of Washington (US)
Corresponding author
David Veesler
Venue
Advances in Virus Research
Publisher
Elsevier
Published
2019
Volume
105
Pages
93-116
ISSN
0065-3527 (ISSN-L)
OpenAlex
W2969525890
Cited by
769
References
133
Citations by year
2026: 10 · 2025: 28 · 2024: 50 · 2023: 66 · 2022: 134 · 2021: 220 · 2020: 257 · 2019: 1
FWCI
399.89
Type
book chapter
Language
en
Open access
Locations
  • Advances in virus research (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Funders
  • National Institute of General Medical Sciences (R01GM120553)
  • National Institute of Allergy and Infectious Diseases (HHSN272201700059C)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
  • Health Sciences › Medicine › Infectious Diseases › Viral Infections and Outbreaks Research
Keywords
coronavirus entry, SARS-CoV, MERS-CoV, viral infection mechanisms, interspecies transmission, zoonotic viruses, viral structural proteins, receptor binding, zoonotic disease outbreaks, bats, Camelus dromedarius
MeSH terms
Animals, Humans, Virion, Coronavirus, Virus Internalization, Host-Pathogen Interactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review